Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 246852-12-0
2. 3-ethyl 5-methyl 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate Methanesulfonate
3. Amlodipine Mesilate
4. 291y33ezha
5. 246852-12-0 (mesylate)
6. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester Methanesulfonate (1:1)
7. 3-o-ethyl 5-o-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate;methanesulfonic Acid
8. 3-ethyl 5-methyl 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate; Methanesulfonic Acid
9. Unii-291y33ezha
10. Amlodipine (mesylate)
11. Schembl1164621
12. Amlodipine (as Mesilate)
13. Hy-b0317c
14. Amy7135
15. Bcp11874
16. Wja85212
17. Amlodipine Mesilate [who-dd]
18. As-75125
19. D93316
20. Q27254365
21. 3-ethyl5-methyl2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylatemethanesulfonate
1. Amilostad
2. Amlodipine Mesylate Monohydrate
3. Amlodipine Mesilate Monohydrate
4. Cardilopina
| Molecular Weight | 505.0 g/mol |
|---|---|
| Molecular Formula | C21H29ClN2O8S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 10 |
| Exact Mass | 504.1333148 g/mol |
| Monoisotopic Mass | 504.1333148 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 739 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Global Sales Information
Market Place
ABOUT THIS PAGE
A Amlodipine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amlodipine Mesylate, including repackagers and relabelers. The FDA regulates Amlodipine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amlodipine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Amlodipine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Amlodipine Mesylate supplier is an individual or a company that provides Amlodipine Mesylate active pharmaceutical ingredient (API) or Amlodipine Mesylate finished formulations upon request. The Amlodipine Mesylate suppliers may include Amlodipine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Amlodipine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Amlodipine Mesylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Amlodipine Mesylate active pharmaceutical ingredient (API) in detail. Different forms of Amlodipine Mesylate DMFs exist exist since differing nations have different regulations, such as Amlodipine Mesylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Amlodipine Mesylate DMF submitted to regulatory agencies in the US is known as a USDMF. Amlodipine Mesylate USDMF includes data on Amlodipine Mesylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Amlodipine Mesylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Amlodipine Mesylate suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Amlodipine Mesylate Drug Master File in Korea (Amlodipine Mesylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Amlodipine Mesylate. The MFDS reviews the Amlodipine Mesylate KDMF as part of the drug registration process and uses the information provided in the Amlodipine Mesylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Amlodipine Mesylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Amlodipine Mesylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Amlodipine Mesylate suppliers with KDMF on PharmaCompass.
A Amlodipine Mesylate written confirmation (Amlodipine Mesylate WC) is an official document issued by a regulatory agency to a Amlodipine Mesylate manufacturer, verifying that the manufacturing facility of a Amlodipine Mesylate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Amlodipine Mesylate APIs or Amlodipine Mesylate finished pharmaceutical products to another nation, regulatory agencies frequently require a Amlodipine Mesylate WC (written confirmation) as part of the regulatory process.
click here to find a list of Amlodipine Mesylate suppliers with Written Confirmation (WC) on PharmaCompass.
Amlodipine Mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amlodipine Mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amlodipine Mesylate GMP manufacturer or Amlodipine Mesylate GMP API supplier for your needs.
A Amlodipine Mesylate CoA (Certificate of Analysis) is a formal document that attests to Amlodipine Mesylate's compliance with Amlodipine Mesylate specifications and serves as a tool for batch-level quality control.
Amlodipine Mesylate CoA mostly includes findings from lab analyses of a specific batch. For each Amlodipine Mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amlodipine Mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Amlodipine Mesylate EP), Amlodipine Mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amlodipine Mesylate USP).
LOOKING FOR A SUPPLIER?
